Key result
ARTD1 deletion in mice fed a high-fat diet exacerbated hepatic steatosis and reduced adipogenic differentiation of adipose-derived stromal cells (11% vs 28% in wild-type).
Why the study?
Does ARTD1 deletion exacerbate hepatic steatosis and impair adipocyte function in mice fed a high-fat diet?
Does ARTD1 deletion exacerbate hepatic steatosis and impair adipocyte function in mice fed a high-fat diet?
Absolute Event Rate: 11% vs 28%
ARTD1 deletion in mice fed a high-fat diet exacerbates hepatic steatosis and impairs adipogenesis, suggesting a role in metabolic homeostasis and nonalcoholic fatty liver disease.
ARTD1 may protect against diet-induced steatosis; hypothesis-generating for NAFLD therapies and requires human validation before any clinical consideration.
ADP‐ribosyltransferase Diphtheria toxinlike 1 [ARTD1; formerly called poly‐ADP‐ribose polymerase 1 (PARP1)] is a chromatin‐associated enzyme involved in regulating metabolic homeostasis. The liver is at the core of glucose and lipid metabolism and is significantly affected by obesity and the metabolic syndrome. Here, we show that when fed a high‐fat diet (HFD), mice lacking ARTD1 developed exacerbated hepatic steatosis. ARTD1 –/– mice had a 19% higher liver weight than wild‐type (WT) animals and exhibited a significantly increased serum concentration of cholesterol (38%) and impaired glucose tolerance. In addition, adipocyte function and size were significantly reduced in ARTD1 –/– mice fed an HFD (7794 μm 2 for WT and 5579 μm 2 for ARTD1 –/– mice). The significantly reduced adipogenic differentiation of adipose‐derived stromal cells (ASCs) isolated from ARTD1 –/– mice (28 vs. 11% Oil red O‐positive cells in WT and ARTD1 –/– ASCs, respectively) suggested that impaired adipogenesis as the underlying cause for this adipose tissue malfunction. This function of ARTD1 was specific for adipogenesis, since osteogenic differentiation was not affected by the ARTD1 deletion. In summary, we show that ARTD1 –/– mice fed an HFD display impaired adipogenesis and show exacerbated hepatic steatosis, which can have important implications for nonalcoholic fatty liver disease.—Erener, S., Mirsaidi, A., Hesse, M., Tiaden, A. N., Ellingsgaard, H., Kostadinova, R., Donath, M. Y., Richards, P. J., Hottiger, M. O. ARTD1 deletion causes increased hepatic lipid accumulation in mice fed a high‐fat diet and impairs adipocyte function and differentiation. FASEB J. 26, 2631‐2638 (2012). www.fasebj.org
No takes yet. Share an insight, caveat, or question.
Erener et al. (2012) studied Hepatic steatosis and impaired adipogenesis. ARTD1 deletion vs. Wild-type (WT) mice was evaluated on Adipogenic differentiation of adipose-derived stromal cells (Oil red O-positive cells). ARTD1 deletion in mice fed a high-fat diet exacerbated hepatic steatosis and reduced adipogenic differentiation of adipose-derived stromal cells (11% vs 28% in wild-type).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: